Pathoanatomical Manifestations of Diabetes Mellitus in Target Organs: An Analysis of Diabetic Nephropathy, Retinopathy, and Cardiomyopathy

Xolieva Nigora Xudayberdiyevna; Davlatova Sadoqat Asliddin qizi; Boytemirova Sadoqat Erali qizi; Tolibov Yunusjon G‘olib o‘g‘li; Jo’raboyeva Gulsevar Ilyosjonovna

Authors

Xolieva Nigora Xudayberdiyevna Tashkent State Medical University, Tashkent, Uzbekistan
Davlatova Sadoqat Asliddin qizi Tashkent State Medical University, Tashkent, Uzbekistan
Boytemirova Sadoqat Erali qizi Tashkent State Medical University, Tashkent, Uzbekistan
Tolibov Yunusjon G‘olib o‘g‘li Tashkent State Medical University, Tashkent, Uzbekistan
Jo’raboyeva Gulsevar Ilyosjonovna Tashkent State Medical University, Tashkent, Uzbekistan

Keywords:

diabetes mellitus, pathological anatomy, diabetic nephropathy, Kimmelstiel–Wilson nodules, diabetic retinopathy, diabetic cardiomyopathy, basement membrane thickening, endothelial dysfunction, histopathology, microangiopathy

Abstract

Background: Diabetes mellitus is a systemic metabolic disease associated with progressive microvascular and tissue injury in the kidneys, retina, and myocardium. Objective: To synthesize the pathoanatomical and histopathological manifestations of diabetic nephropathy, retinopathy, and cardiomyopathy and relate their structural features to clinical dysfunction. Materials and Methods: A narrative clinical–morphological analysis of published biopsy, autopsy, and histopathological descriptions was conducted, supported by educational observations of microscopic sections and autopsy material. The analysis focused on hematoxylin–eosin, periodic acid–Schiff, and Van Gieson staining patterns and established morphological classifications. Results: In the kidneys, basement-membrane thickening, mesangial expansion, nodular Kimmelstiel–Wilson glomerulosclerosis, and tubulointerstitial fibrosis characterize progressive damage. Retinal changes include pericyte loss, microaneurysm formation, exudation, ischemic lesions, and VEGF-associated neovascularization. Myocardial changes comprise cardiomyocyte dystrophy, intramyocardial microangiopathy, and interstitial or perivascular fibrosis, potentially contributing to diastolic dysfunction. Conclusion: These organ-specific lesions reflect overlapping mechanisms of chronic hyperglycemia, microvascular injury, and tissue remodeling. Integrated clinicopathological assessment is important for recognizing diabetic complications. The work is a descriptive literature-based analysis and does not present an original quantified patient cohort.

References

[1] American Diabetes Association, “12. Retinopathy, neuropathy, and foot care: Standards of care in diabetes—2023,” Diabetes Care, vol. 46, suppl. 1, pp. S203–S215, 2023, doi: 10.2337/dc23-S012.

[2] Tashkent Medical Academy, “Analysis of pathomorphological and histological changes in organs and tissues in diabetes mellitus,” CyberLeninka Scientific Library, 2021. [Online]. Available: https://cyberleninka.ru/article/n/qandli-diabetda-buyraklar-patomorfologiyasi.

[3] “The pathophysiological mechanisms underlying diabetic retinopathy: Microvascular and structural alterations,” Frontiers in Cell and Developmental Biology, vol. 10, Art. no. 963615, 2022. [Online]. Available: https://doi.org/10.3389/fcell.2022.963615.

[4] “Diabetic retinopathy: Current understanding, mechanisms, and cellular pathomorphology,” JCI Insight, vol. 2, no. 13, Art. no. e93751, 2017. [Online]. Available: https://insight.jci.org/articles/view/93751.

[5] M. E. Tervaert et al., “Pathologic classification of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 21, no. 4, pp. 556–563, 2010, doi: 10.1681/ASN.2010010010.

[6] “Diabetic retinopathy, a comprehensive overview on mechanisms, histopathology, and pathogenesis,” International Journal of Molecular Sciences, vol. 26, no. 20, Art. no. 9882, 2025. [Online]. Available: https://www.mdpi.com/1422-0067/26/20/9882.

[7] “Classification and differential diagnosis of diabetic nephropathy: Pathological features and Kimmelstiel–Wilson lesions,” PubMed Central, 2017. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC5337846/.

[8] “Target organ damage and incident type 2 diabetes mellitus: Cardiorenal morphological study,” PubMed Central, 2017. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC5427627/.

[9] M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, pp. 813–820, 2001, doi: 10.1038/414813a.

[10] S. M. M. Forbes and M. E. Cooper, “Mechanisms of diabetic complications,” Physiological Reviews, vol. 93, no. 1, pp. 137–188, 2013, doi: 10.1152/physrev.00045.2011.

[11] R. N. Frank, “Diabetic retinopathy,” New England Journal of Medicine, vol. 350, no. 1, pp. 48–58, 2004, doi: 10.1056/NEJMra021678.

[12] R. Klein, B. E. K. Klein, and S. E. Moss, “The Wisconsin Epidemiologic Study of Diabetic Retinopathy: A review,” Diabetes/Metabolism Reviews, vol. 5, no. 7, pp. 559–570, 1989.

[13] F. C. Brosius III et al., “Mouse models of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 20, no. 12, pp. 2503–2512, 2009, doi: 10.1681/ASN.2009070721.

[14] American Diabetes Association Professional Practice Committee, “12. Retinopathy, neuropathy, and foot care: Standards of care in diabetes—2025,” Diabetes Care, vol. 48, suppl. 1, pp. S252–S265, 2025, doi: 10.2337/dc25-S012.

[15] P. Fioretto and M. Mauer, “Histopathology of diabetic nephropathy,” Seminars in Nephrology, vol. 27, no. 2, pp. 195–207, 2007.